Metabolic, hormonal and immunological associations with global DNA methylation among postmenopausal women

Epigenetics

Volumn 7, Issue 9, 2012, Pages 1020-1028

  Ulrich, Cornelia M ^a,b   Toriola, Adetunji T ^a   Koepl, Lisel M ^b   Sandifer, Tracy ^c   Poole, Elizabeth M ^b,d,e   Duggan, Catherine ^b   McTiernan, Anne ^b   Issa, Jean Pierre J ^f  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b Fred Hutchinson Cancer Research Center   (United States)

^c WASHINGTON STATE DEPARTMENT OF HEALTH   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^f UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

DNA methylation; Epidemiology; Epigenetics; Folate; Glucose; Immune function; Inflammation; Metabolic; Post menopausal; Sex hormones; Women

Indexed keywords

BIOLOGICAL MARKER; CARBON; CD4 ANTIGEN; CD8 ANTIGEN; DNA; ESTRADIOL; ESTRONE; FOLIC ACID; GLUCOSE; IMMUNOGLOBULIN A; LIPID; MULTIVITAMIN; PYRIDOXINE; SEX HORMONE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ADULT; AGED; ARTICLE; CONCENTRATION (PARAMETERS); DIET; DNA METHYLATION; FEMALE; FOLIC ACID BLOOD LEVEL; GENETIC ASSOCIATION; HUMAN; INFLAMMATION; LONG INTERSPERSED REPEAT; LYMPHOCYTE; MAJOR CLINICAL STUDY; OBESITY; POSTMENOPAUSE; PYROSEQUENCING; STUDENT T TEST;

EID: 84866062895     PISSN: 15592294     EISSN: 15592308     Source Type: Journal    
DOI: 10.4161/epi.21464     Document Type: Article

References (75)

1. Jones PA, Takai D. The role of DNA methylation in mammalian epigenetics. Science 2001; 293:1068-70; http://dx.doi.org/10.1126/sci-ence.1063852.
2. Baylin SB, Herman JG, Graff JR, Vertino PM, Issa JP. Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv Cancer Res 1998; 72:141-96; http://dx.doi.org/10.1016/S0065-230X(08)60702-2.
3. Laird PW, Jaenisch R. DNA methylation and can-cer. Hum Mol Genet 1994; 3(Spec No):1487-95;
4. Toyota M, Issa JP. Epigenetic changes in solid and hematopoietic tumors. Semin Oncol 2005; 32:521-30; http://dx.doi.org/10.1053/j.semi-noncol.2005.07.003.
5. Choi JY, James SR, Link PA, McCann SE, Hong CC, Davis W, et al. Association between global DNA hypo-methylation in leukocytes and risk of breast cancer. Carcinogenesis 2009; 30:1889-97; http://dx.doi.org/10.1093/carcin/bgp143.
6. Feinberg AP, Vogelstein B. Hypomethylation dis-tinguishes genes of some human cancers from their normal counterparts. Nature 1983; 301:89-92; http://dx.doi.org/10.1038/301089a0.
7. Robertson KD. DNA methylation and human disease. Nat Rev Genet 2005; 6:597-610; http://dx.doi.org/10.1038/nrg1655.
8. Kim M, Long TI, Arakawa K, Wang R, Yu MC, Laird PW. DNA methylation as a biomarker for cardiovascular disease risk. PLoS One 2010; 5:e9692; http://dx.doi.org/10.1371/journal.pone.0009692.
9. Liu CC, Ou TT, Wu CC, Li RN, Lin YC, Lin CH, et al. Global DNA methylation, DNMT1, and MBD2 in patients with systemic lupus erythematosus. Lupus 2011; 20:131-6; http://dx.doi.org/10.1177/0961203310381517.
10. Issa JP. CpG island methylator phenotype in cancer. Nat Rev Cancer 2004; 4:988-93; http://dx.doi.org/10.1038/nrc1507.
11. Chalitchagorn K, Shuangshoti S, Hourpai N, Kongruttanachok N, Tangkijvanich P, Thong-ngam D, et al. Distinctive pattern of LINE-1 methylation level in normal tissues and the association with carcinogen-esis. Oncogene 2004; 23:8841-6; http://dx.doi.org/10.1038/sj.onc.1208137.
12. Ulrich CM, Grady WM. Linking epidemiology to epigenomics--where are we today? Cancer Prev Res (Phila) 2010; 3:1505-8; http://dx.doi.org/10.1158/1940-6207.CAPR-10-0298.
13. Issa JP, Shen L, Toyota M. CIMP, at last. Gastroenterology 2005; 129:1121-4; http://dx.doi.org/10.1053/j.gastro.2005.07.040.
14. Teitell M, Richardson B. DNA methylation in the immune system. Clin Immunol 2003; 109:2-5; http://dx.doi.org/10.1016/S1521-6616(03)00224-9.
15. Kim YI. Folate and DNA methylation: a mechanistic link between folate deficiency and colorectal cancer? Cancer Epidemiol Biomarkers Prev 2004; 13:511-9;
16. Zhu ZZ, Hou L, Bollati V, Tarantini L, Marinelli B, Cantone L, et al. Predictors of global methylation levels in blood DNA of healthy subjects: a combined analysis. Int J Epidemiol 2012; 41:126-39; http://dx.doi.org/10.1093/ije/dyq154.
17. Borghol N, Suderman M, McArdle W, Racine A, Hallett M, Pembrey M, et al. Associations with early-life socio-economic position in adult DNA methylation. Int J Epidemiol 2011; 41:62-74;
18. Tost J. DNA methylation: an introduction to the biology and the disease-associated changes of a prom-ising biomarker. Mol Biotechnol 2010; 44:71-81; http://dx.doi.org/10.1007/s12033-009-9216-2.
19. Fraga MF, Ballestar E, Paz MF, Ropero S, Setien F, Ballestar ML, et al. Epigenetic differences arise during the lifetime of monozygotic twins. Proc Natl Acad Sci U S A 2005; 102:10604-9; http://dx.doi.org/10.1073/pnas.0500398102.
20. Terry MB, Ferris JS, Pilsner R, Flom JD, Tehranifar P, Santella RM, et al. Genomic DNA methylation among women in a multiethnic New York City birth cohort. Cancer Epidemiol Biomarkers Prev 2008; 17:2306-10; http://dx.doi.org/10.1158/1055-9965.EPI-08-0312.
21. Rampersaud GC, Kauwell GP, Hutson AD, Cerda JJ, Bailey LB. Genomic DNA methylation decreases in response to moderate folate depletion in elder-ly women. Am J Clin Nutr 2000; 72:998-1003;
22. Keyes MK, Jang H, Mason JB, Liu Z, Crott JW, Smith DE, et al. Older age and dietary folate are determinants of genomic and p16-specific DNA meth-ylation in mouse colon. J Nutr 2007; 137:1713-7;
23. El-Maarri O, Becker T, Junen J, Manzoor SS, Diaz-Lacava A, Schwaab R, et al. Gender specific differences in levels of DNA methylation at selected loci from human total blood: a tendency toward higher meth-ylation levels in males. Hum Genet 2007; 122:505-14; http://dx.doi.org/10.1007/s00439-007-0430-3.
24. Choi SW, Stickel F, Baik HW, Kim YI, Seitz HK, Mason JB. Chronic alcohol consumption induces genomic but not p53-specific DNA hypomethylation in rat colon. J Nutr 1999; 129:1945-50;
25. Schernhammer ES, Giovannucci E, Kawasaki T, Rosner B, Fuchs CS, Ogino S. Dietary folate, alcohol and B vitamins in relation to LINE-1 hypomethylation in colon cancer. Gut 2010; 59:794-9; http://dx.doi.org/10.1136/gut.2009.183707.
26. El-Maarri O, Walier M, Behne F, van Üüm J, Singer H, Diaz-Lacava A, et al. Methylation at global LINE-1 repeats in human blood are affected by gender but not by age or natural hormone cycles. PLoS One 2011; 6:e16252; http://dx.doi.org/10.1371/journal.pone.0016252.
27. Estécio MR, Gharibyan V, Shen L, Ibrahim AE, Doshi K, He R, et al. LINE-1 hypomethylation in cancer is highly variable and inversely correlated with microsatellite instability. PLoS One 2007; 2:e399; http://dx.doi.org/10.1371/journal.pone.0000399.
28. Suter CM, Martin DI, Ward RL. Hypomethylation of L1 retrotransposons in colorectal cancer and adjacent normal tissue. Int J Colorectal Dis 2004; 19:95-101; http://dx.doi.org/10.1007/s00384-003-0539-3.
29. Figueiredo JC, Grau MV, Wallace K, Levine AJ, Shen L, Hamdan R, et al. Global DNA hypomethylation (LINE-1) in the normal colon and lifestyle characteris-tics and dietary and genetic factors. Cancer Epidemiol Biomarkers Prev 2009; 18:1041-9; http://dx.doi.org/10.1158/1055-9965.EPI-08-0926.
30. Zhang FF, Cardarelli R, Carroll J, Fulda KG, Kaur M, Gonzalez K, et al. Significant differences in global genomic DNA methylation by gender and race/eth-nicity in peripheral blood. Epigenetics 2011; 6:623-9; http://dx.doi.org/10.4161/epi.6.5.15335.
31. Chiang EP, Wang YC, Chen WW, Tang FY. Effects of insulin and glucose on cellular metabolic flux-es in homocysteine transsulfuration, remethylation, S-adenosylmethionine synthesis, and global deoxyri-bonucleic acid methylation. J Clin Endocrinol Metab 2009; 94:1017-25; http://dx.doi.org/10.1210/jc.2008-2038.
32. Williams KT, Schalinske KL. New insights into the regulation of methyl group and homocysteine metabo-lism. J Nutr 2007; 137:311-4;
33. Kim YI. Folate, colorectal carcinogenesis, and DNA methylation: lessons from animal studies. Environ Mol Mutagen 2004; 44:10-25; http://dx.doi.org/10.1002/em.20025.
34. Dolinoy DC, Huang D, Jirtle RL. Maternal nutri-ent supplementation counteracts bisphenol A-induced DNA hypomethylation in early development. Proc Natl Acad Sci U S A 2007; 104:13056-61; http://dx.doi.org/10.1073/pnas.0703739104.
35. Paz MF, Avila S, Fraga MF, Pollan M, Capella G, Peinado MA, et al. Germ-line variants in methyl-group metabolism genes and susceptibility to DNA meth-ylation in normal tissues and human primary tumors. Cancer Res 2002; 62:4519-24;
36. Curtin K, Slattery ML, Ulrich CM, Bigler J, Levin TR, Wolff RK, et al. Genetic polymorphisms in one-carbon metabolism: associations with CpG island methylator phenotype (CIMP) in colon cancer and the modify-ing effects of diet. Carcinogenesis 2007; 28:1672-9; http://dx.doi.org/10.1093/carcin/bgm089.
37. Pufulete M, Al-Ghnaniem R, Khushal A, Appleby P, Harris N, Gout S, et al. Effect of folic acid supplementation on genomic DNA methylation in patients with colorectal adenoma. Gut 2005; 54:648-53; http://dx.doi.org/10.1136/gut.2004.054718.
38. Shelnutt KP, Kauwell GP, Gregory JF 3rd, Maneval DR, Quinlivan EP, Theriaque DW, et al. Methylenetetrahydrofolate reductase 677C-->T poly-morphism affects DNA methylation in response to controlled folate intake in young women. J Nutr Biochem 2004; 15:554-60; http://dx.doi.org/10.1016/j.jnutbio.2004.04.003.
39. Jacob RA, Gretz DM, Taylor PC, James SJ, Pogribny IP, Miller BJ, et al. Moderate folate depletion increases plasma homocysteine and decreases lymphocyte DNA methylation in postmenopausal women. J Nutr 1998; 128:1204-12;
40. Friso S, Choi SW, Girelli D, Mason JB, Dolnikowski GG, Bagley PJ, et al. A common mutation in the 5,10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interac-tion with folate status. Proc Natl Acad Sci U S A 2002; 99:5606-11; http://dx.doi.org/10.1073/pnas.062066299.
41. Pearce MS, McConnell JC, Potter C, Barrett LM, Parker L, Mathers JC, et al. Global LINE-1 DNA methylation is associated with blood glycaemic and lipid profiles. Int J Epidemiol 2012; 41:210-7; http://dx.doi.org/10.1093/ije/dys020.
42. Zhao J, Goldberg J, Bremner JD, Vaccarino V. Global DNA Methylation Is Associated With Insulin Resistance: A Monozygotic Twin Study. Diabetes 2011; 61:542-6;
43. Jiang MH, Fei J, Lan MS, Lu ZP, Liu M, Fan WW, et al. Hypermethylation of hepatic Gck promoter in ageing rats contributes to diabetogenic potential. Diabetologia 2008; 51:1525-33; http://dx.doi.org/10.1007/s00125-008-1034-8.
44. Issa JP. Age-related epigenetic changes and the immune system. Clin Immunol 2003; 109:103-8; http://dx.doi.org/10.1016/S1521-6616(03)00203-1.
45. Cho NY, Kim BH, Choi M, Yoo EJ, Moon KC, Cho YM, et al. Hypermethylation of CpG island loci and hypomethylation of LINE-1 and Alu repeats in prostate adenocarcinoma and their relationship to clinicopathological features. J Pathol 2007; 211:269-77; http://dx.doi.org/10.1002/path.2106.
46. Moore LE, Pfeiffer RM, Poscablo C, Real FX, Kogevinas M, Silverman D, et al. Genomic DNA hypomethylation as a biomarker for bladder cancer susceptibility in the Spanish Bladder Cancer Study: a case-control study. Lancet Oncol 2008; 9:359-66; http://dx.doi.org/10.1016/S1470-2045(08)70038-X.
47. Ogino S, Kawasaki T, Nosho K, Ohnishi M, Suemoto Y, Kirkner GJ, et al. LINE-1 hypomethylation is inversely associated with microsatellite instability and CpG island methylator phenotype in colorectal cancer. Int J Cancer 2008; 122:2767-73; http://dx.doi.org/10.1002/ijc.23470.
48. Bjornsson HT, Sigurdsson MI, Fallin MD, Irizarry RA, Aspelund T, Cui H, et al. Intra-individual change over time in DNA methylation with familial clustering. JAMA 2008; 299:2877-83; http://dx.doi.org/10.1001/jama.299.24.2877.
49. Fuke C, Shimabukuro M, Petronis A, Sugimoto J, Oda T, Miura K, et al. Age related changes in 5-methyl-cytosine content in human peripheral leukocytes and placentas: an HPLC-based study. Ann Hum Genet 2004; 68:196-204; http://dx.doi.org/10.1046/j.1529-8817.2004.00081.x.
50. Bollati V, Schwartz J, Wright R, Litonjua A, Tarantini L, Suh H, et al. Decline in genomic DNA meth-ylation through aging in a cohort of elderly subjects. Mech Ageing Dev 2009; 130:234-9; http://dx.doi.org/10.1016/j.mad.2008.12.003.
51. Terry MB, Delgado-Cruzata L, Vin-Raviv N, Wu HC, Santella RM. DNA methylation in white blood cells: association with risk factors in epidemiologic studies. Epigenetics 2011; 6:828-37; http://dx.doi.org/10.4161/epi.6.7.16500.
52. Hamid A, Wani NA, Kaur J. New perspectives on folate transport in relation to alcoholism-induced folate malabsorption--association with epigenome stability and cancer development. FEBS J 2009; 276:2175-91; http://dx.doi.org/10.1111/j.1742-4658.2009.06959.x.
53. Crider KS, Quinlivan EP, Berry RJ, Hao L, Li Z, Maneval D, et al. Genomic DNA methylation chang-es in response to folic acid supplementation in a population-based intervention study among women of reproductive age. PLoS One 2011; 6:e28144; http://dx.doi.org/10.1371/journal.pone.0028144.
54. Ulrich CM. Nutrigenetics in cancer research--folate metabolism and colorectal cancer. J Nutr 2005; 135:2698-702;
55. Slattery ML, Potter JD, Samowitz W, Schaffer D, Leppert M. Methylenetetrahydrofolate reductase, diet, and risk of colon cancer. Cancer Epidemiol Biomarkers Prev 1999; 8:513-8;
56. Richardson B, Scheinbart L, Strahler J, Gross L, Hanash S, Johnson M. Evidence for impaired T cell DNA methylation in systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum 1990; 33:1665-73; http://dx.doi.org/10.1002/art.1780331109.
57. Golbus J, Palella TD, Richardson BC. Quantitative changes in T cell DNA methylation occur during dif-ferentiation and ageing. Eur J Immunol 1990; 20:1869-72; http://dx.doi.org/10.1002/eji.1830200836.
58. Weisenberger DJ, Campan M, Long TI, Kim M, Woods C, Fiala E, et al. Analysis of repetitive element DNA methylation by MethyLight. Nucleic Acids Res 2005; 33:6823-36; http://dx.doi.org/10.1093/nar/gki987.
59. McTiernan A, Ulrich CM, Yancey D, Slate S, Nakamura H, Oestreicher N, et al. The Physical Activity for Total Health (PATH) Study: rationale and design. Med Sci Sports Exerc 1999; 31:1307-12; http://dx.doi.org/10.1097/00005768-199909000-00012.
60. Patterson RE, Kristal AR, Tinker LF, Carter RA, Bolton MP, Agurs-Collins T. Measurement charac-teristics of the Women's Health Initiative food fre-quency questionnaire. Ann Epidemiol 1999; 9:178-87; http://dx.doi.org/10.1016/S1047-2797(98)00055-6.
61. Toyota M, Ho C, Ahuja N, Jair KW, Li Q, Ohe-Toyota M, et al. Identification of differentially methylated sequences in colorectal cancer by methylated CpG island amplification. Cancer Res 1999; 59:2307-12;
62. Frank LL, Sorensen BE, Yasui Y, Tworoger SS, Schwartz RS, Ulrich CM, et al. Effects of exercise on metabolic risk variables in overweight postmenopausal women: a randomized clinical trial. Obes Res 2005; 13:615-25; http://dx.doi.org/10.1038/oby.2005.66.
63. Foster-Schubert KE, McTiernan A, Frayo RS, Schwartz RS, Rajan KB, Yasui Y, et al. Human plasma ghrelin lev-els increase during a one-year exercise program. J Clin Endocrinol Metab 2005; 90:820-5; http://dx.doi.org/10.1210/jc.2004-2081.
64. McTiernan A, Tworoger SS, Rajan KB, Yasui Y, Sorenson B, Ulrich CM, et al. Effect of exercise on serum androgens in postmenopausal women: a 12-month ran-domized clinical trial. Cancer Epidemiol Biomarkers Prev 2004; 13:1099-105;
65. Mohanka M, Irwin M, Heckbert SR, Yasui Y, Sorensen B, Chubak J, et al. Serum lipoproteins in over-weight/obese postmenopausal women: a one-year exercise trial. Med Sci Sports Exerc 2006; 38:231-9; http://dx.doi.org/10.1249/01.mss.0000184584.95000.e4.
66. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the prepara-tive ultracentrifuge. Clin Chem 1972; 18:499-502;
67. Bagley PJ, Selhub J. Analysis of folate form distribution by affinity followed by reversed- phase chromatography with electrical detection. Clin Chem 2000; 46:404-11;
68. Shade ED, McTiernan A, Wener MH, Wood B, Yasui Y, LaCroix K, et al. Frequent intentional weight loss is associated with lower natural killer cell cyto-toxicity constituting possible long-term effects on immune function. J Am Diet Assoc 2004; 104:903-12; http://dx.doi.org/10.1016/j.jada.2004.03.018.
69. Meyers JA, Liu AY, McTiernan A, Wener MH, Wood B, Weigle DS, et al. Serum leptin concentrations and markers of immune function in overweight or obese postmenopausal women. J Endocrinol 2008; 199:51-60; http://dx.doi.org/10.1677/JOE-07-0569.
70. McTiernan A, Tworoger SS, Ulrich CM, Yasui Y, Irwin ML, Rajan KB, et al. Effect of exercise on serum estrogens in postmenopausal women: a 12-month randomized clinical trial. Cancer Res 2004; 64:2923-8; http://dx.doi.org/10.1158/0008-5472.CAN-03-3393.
71. Probst-Hensch NM, Ingles SA, Diep AT, Haile RW, Stanczyk FZ, Kolonel LN, et al. Aromatase and breast cancer susceptibility. Endocr Relat Cancer 1999; 6:165-73; http://dx.doi.org/10.1677/erc.0.0060165.
72. Goebelsmann U, Bernstein GS, Gale GA, Kletzky OA, Nakamura RM, Coulson AH, et al. Serum gonado-tropin, testosterone, estradiol and estrone levels prior to and following bilateral vasectomy. In: Lepow IH, Crozier R, eds. Vasectomy: immunologic and patho-physiologic effects in animals and man. New York: Academic Press, 1979: 165-181.
73. Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 1999; 84:3666-72; http://dx.doi.org/10.1210/jc.84.10.3666.
74. Södergård R, Bäckström T, Shanbhag V, Carstensen H. Calculation of free and bound fractions of testosterone and estradiol-17 beta to human plasma proteins at body temperature. J Steroid Biochem 1982; 16:801-10; http://dx.doi.org/10.1016/0022-4731(82)90038-3.
75. Rinaldi S, Geay A, Déchaud H, Biessy C, Zeleniuch-Jacquotte A, Akhmedkhanov A, et al. Validity of free testosterone and free estradiol determinations in serum samples from postmenopausal women by theoretical calculations. Cancer Epidemiol Biomarkers Prev 2002; 11:1065-71;